(Q46562532)

English

Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain

scientific article published in June 2005

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

title

Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

main subject

relapsing-remitting multiple sclerosis

0 references

1 reference

Rubio-Terrés C

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

Domínguez-Gil Hurlé A

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

publication date

1 June 2005

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

published in

Revista de neurología

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

volume

40

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

issue

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

page(s)

705-710

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

retrieved

13 January 2020

Identifiers

PubMed publication ID

15973634

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15973634

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15973634%20AND%20SRC:MED&resulttype=core&format=json

(Q46562532)

Cost-utility analysis of relapsing-remitting multiple sclerosis treatment with azathioprine or interferon beta in Spain

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)